Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 65% ± 23% | |
GABAergic neuron | 10 studies | 69% ± 20% | |
neuron | 8 studies | 58% ± 20% | |
amacrine cell | 8 studies | 67% ± 17% | |
interneuron | 7 studies | 67% ± 21% | |
retinal ganglion cell | 7 studies | 61% ± 29% | |
retina horizontal cell | 6 studies | 69% ± 7% | |
retinal bipolar neuron | 5 studies | 23% ± 7% | |
granule cell | 4 studies | 64% ± 14% | |
GABAergic amacrine cell | 4 studies | 73% ± 9% | |
glycinergic amacrine cell | 4 studies | 58% ± 18% | |
OFF-bipolar cell | 4 studies | 46% ± 26% | |
endothelial cell | 3 studies | 48% ± 22% | |
GABAergic interneuron | 3 studies | 81% ± 10% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 6% | |
ON-bipolar cell | 3 studies | 42% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 7662.05 | 2524 / 2642 | 88% | 15.82 | 622 / 705 |
adrenal gland | 13% | 165.38 | 33 / 258 | 71% | 43.69 | 164 / 230 |
ovary | 0% | 0 | 0 / 180 | 81% | 2.84 | 347 / 430 |
thymus | 0% | 0 | 0 / 653 | 63% | 2.12 | 382 / 605 |
pancreas | 0% | 1.77 | 1 / 328 | 34% | 1.59 | 61 / 178 |
uterus | 0% | 0 | 0 / 170 | 31% | 0.75 | 140 / 459 |
kidney | 0% | 0 | 0 / 89 | 22% | 0.47 | 201 / 901 |
lung | 0% | 0 | 0 / 578 | 22% | 0.59 | 252 / 1155 |
breast | 0% | 0 | 0 / 459 | 15% | 0.76 | 164 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.77 | 5 / 45 |
prostate | 2% | 18.03 | 6 / 245 | 9% | 0.19 | 43 / 502 |
stomach | 0% | 1.62 | 1 / 359 | 8% | 0.22 | 24 / 286 |
esophagus | 0% | 0.38 | 1 / 1445 | 7% | 0.31 | 12 / 183 |
intestine | 2% | 12.87 | 18 / 966 | 5% | 0.17 | 25 / 527 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.31 | 30 / 504 |
liver | 0% | 0 | 0 / 226 | 5% | 0.13 | 21 / 406 |
skin | 0% | 0.62 | 1 / 1809 | 4% | 0.11 | 20 / 472 |
eye | 0% | 0 | 0 / 0 | 3% | 0.16 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_1902866 | Biological process | regulation of retina development in camera-type eye |
GO_0001701 | Biological process | in utero embryonic development |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0007281 | Biological process | germ cell development |
GO_0090394 | Biological process | negative regulation of excitatory postsynaptic potential |
GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
GO_0017148 | Biological process | negative regulation of translation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0098794 | Cellular component | postsynapse |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0042835 | Molecular function | BRE binding |
GO_0036002 | Molecular function | pre-mRNA binding |
Gene name | CELF4 |
Protein name | CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4) CUGBP Elav-like family member 4 CUGBP Elav-like family member 4 (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4) |
Synonyms | BRUNOL4 |
Description | FUNCTION: RNA-binding protein implicated in the regulation of pre-mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Promotes exclusion of both the smooth muscle (SM) and non-muscle (NM) exons in actinin pre-mRNAs. Activates the splicing of MAPT/Tau exon 10. Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. . |
Accessions | ENST00000587819.5 B4DHA8 ENST00000593271.5 K7EJ26 K7EJD7 ENST00000587657.1 ENST00000589229.5 ENST00000587911.5 K7ERH1 ENST00000588597.5 M0QY66 Q9BZC1 ENST00000361795.9 [Q9BZC1-3] A0A0C4DGR1 ENST00000586009.5 ENST00000588591.5 K7ENR2 K7EJK3 M0R137 ENST00000591282.5 [Q9BZC1-1] ENST00000589386.5 ENST00000590112.5 A0A0A0MTT3 K7EJW4 K7EPX2 K7EQ97 ENST00000603232.6 [Q9BZC1-4] ENST00000601019.5 ENST00000420428.7 [Q9BZC1-1] ENST00000591287.5 [Q9BZC1-2] ENST00000601392.5 ENST00000334919.9 [Q9BZC1-5] ENST00000587924.1 |